Definium Therapeutics, Inc. (DFTX)
NASDAQ: DFTX · Real-Time Price · USD
21.27
+0.29 (1.38%)
At close: Apr 28, 2026, 4:00 PM EDT
21.29
+0.02 (0.09%)
After-hours: Apr 28, 2026, 6:17 PM EDT
Definium Therapeutics Employees
As of December 31, 2025, Definium Therapeutics had 106 total employees, including 105 full-time and 1 part-time employees. The number of employees increased by 32 or 43.24% compared to the previous year.
Employees
106
Change (1Y)
32
Growth (1Y)
43.24%
Revenue / Employee
n/a
Profits / Employee
-$1,733,896
Market Cap
2.12B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Sarepta Therapeutics | 835 |
| Ascentage Pharma Group International | 767 |
| Adaptive Biotechnologies | 624 |
| Ocular Therapeutix | 325 |
| Zymeworks | 264 |
| Capricor Therapeutics | 231 |
| Stoke Therapeutics | 170 |
| Aurinia Pharmaceuticals | 128 |
DFTX News
- 6 days ago - Definium Therapeutics Highlights DT120 ODT (Lysergide Tartrate) Clinical Advancements and Commercial Strategy at Investor and Analyst Day - Business Wire
- 6 days ago - Definium Therapeutics Transcript: Investor Day 2026 - Transcripts
- 8 days ago - Definium Therapeutics Announces New Employee Inducement Grants - Business Wire
- 8 days ago - How Trump's psychedelics executive order could unlock stalled cannabis reform - CNBC
- 8 days ago - Psychedelic Stocks Surge After Trump Signs Order Fast-Tracking Drug Research - Forbes
- 8 days ago - Psychedelic stocks rally with Trump's support - Market Watch
- 8 days ago - Trump Signs Order to Fast-Track Psychedelic Drugs. AtaiBeckley and These Other Stocks Are Soaring. - Barrons
- 8 days ago - Psychedelic drug makers rally as Trump orders FDA to expedite reviews - Reuters